DDB as an agent against BEL-7402 human hepatocarcinoma

Details DDB as an agent against BEL-7402 human hepatocarcinoma DDB as an agent against BEL-7402 human hepatocarcinoma

1990-05-07

1992-10-13

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514464, H61K 3152, H61K 3136

Patent

active

051551110

ABSTRACT:
Dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2,2'-dicarboxyla te (DDB), a synthetic analogue of Schizandrin C, is a useful chemotherapeutic agent for the treatment of BEL-7402 human hepatocarcinoma when used in combination with 6-mercaptopurine.

REFERENCES:
Chemical Abstracts 104:109612t (1986).
Chemical Abstracts 108:81931c (1988).

Affiliated with

Also associated with

Rating

DDB as an agent against BEL-7402 human hepatocarcinoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with DDB as an agent against BEL-7402 human hepatocarcinoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DDB as an agent against BEL-7402 human hepatocarcinoma will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1300600